CABOT EARNINGS TELECONFERENCE Third Quarter - Fiscal 2024 Forward Looking Statements This presentation contains forward-looking statements. All statements that address expectations or projections about the future, including with respect to our expectations for our performance in fiscal 2024, including for adjusted EPS and the expected performance of our business segments for the remainder of fiscal 2024, for strong cash flows from operations and discretionary free cash flow in fiscal 2024 and our anticipate ...

Cabot Corporation (CBT) recorded third-quarter fiscal 2024 (ended Jun 30, 2024) earnings of $1.94 per share, up from the year-ago quarter's $1.43. CBT posted adjusted earnings of $1.92 per share, up from the year-ago quarter's figure of $1.42. Adjusted earnings beat the Zacks Consensus Estimate of $1.74. The company's net sales in the quarter were $1,016 million, which beat the Zacks Consensus Estimate of $1,010.1 million. Net sales increased around 4.9% from the prior-year quarter. Segment Highlights Reinf ...

Exhibit 99.1 Investor Contact: Steve Delahunt (617) 342-6255 CABOT CORP REPORTS THIRD QUARTER FISCAL 2024 RESULTS Diluted earnings per share ("EPS") of $1.94 and Adjusted EPS of $1.92 BOSTON (August 5, 2024)-- Cabot Corporation (NYSE: CBT) today announced results for its third quarter of fiscal year 2024. Key Highlights Diluted EPS of $1.94 and Adjusted EPS of $1.92, which represents a 35% increase in Adjusted EPS as compared to the same quarter in the prior year Reinforcement Materials segment EBIT of $136 ...

Chicago, IL – July 19, 2024 – Today, Zacks Equity Research discusses Eastman Chemical Co. (EMN) , Cabot Corp. (CBT) and Kronos Worldwide, Inc. (KRO) . Link: https://www.zacks.com/commentary/2304134/3-diversified-chemical-stocks-to-escape-industryheadwinds Industry players like Eastman Chemical Co., Cabot Corp. and Kronos Worldwide, Inc. are banking on strategic measures, including operating cost reductions and aggressive price hikes, to tide over the challenging environment. The Zacks Chemicals Diversified ...

Core Viewpoint - The chemicals diversified industry is facing significant challenges due to demand weakness in key markets, particularly in Europe and China, driven by economic slowdowns and inflationary pressures [2][14]. Industry Overview - The Zacks Chemicals Diversified industry includes manufacturers of basic chemicals, plastics, specialty chemicals, and agricultural chemicals, serving various end markets such as automotive, construction, and agriculture [5]. - The industry has underperformed compared to the S&P 500 and the broader sector, declining by 7.8% while the S&P 500 rose by 23.4% [7][19]. Demand Challenges - Demand is being hindered by sluggishness in the building & construction market and destocking in consumer electronics, with uncertainties in the U.S. housing market exacerbating the situation [6][14]. - The ongoing weakness in Europe and a slow recovery in China are further impacting chemical demand, with inflation and high interest rates leading to reduced consumer spending [2][14]. Strategic Responses - Companies like Eastman Chemical, Cabot Corporation, and Kronos Worldwide are implementing strategic measures such as cost reductions and aggressive price hikes to navigate the challenging environment [4][16]. - The industry is currently trading at an EV/EBITDA ratio of 10.7X, below the S&P 500's 20.11X and the sector's 11.94X, indicating potential undervaluation [8]. Company Highlights - Cabot Corporation, with a Zacks Rank 2 (Buy), is expected to see earnings growth of 26% for fiscal 2024, driven by strong performance in its Reinforcement Materials segment [12][27]. - Eastman Chemical, holding a Zacks Rank 3 (Hold), anticipates earnings growth of 20.2% for 2024, supported by its innovation-driven growth model and operational efficiency [30]. - Kronos Worldwide, rated Zacks Rank 1 (Strong Buy), is projected to achieve earnings growth of 297.7% for 2024, benefiting from higher demand for titanium dioxide and reduced energy costs [24][25].

Here at Zacks, we focus on our proven ranking system, which places an emphasis on earnings estimates and estimate revisions, to find winning stocks. But we also understand that investors develop their own strategies, so we are constantly looking at the latest trends in value, growth, and momentum to find strong companies for our readers. Of these, perhaps no stock market trend is more popular than value investing, which is a strategy that has proven to be successful in all sorts of market environments. Valu ...

Investors with an interest in Chemical - Diversified stocks have likely encountered both Cabot (CBT) and Air Liquide (AIQUY) . But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. Right now, Cabot is sporting a Zacks Rank of #2 (Buy), while Air Liquide has a Zacks Rank of #4 (Sell). This system places an emphasis on companies that have seen positive earnings estimate revisions, so investors should feel comfortable knowing that CBT is likely seein ...

Another Basic Materials stock, which has outperformed the sector so far this year, is AngloGold Ashanti (AU) . The stock has returned 24.7% year-to-date. Investors interested in Basic Materials stocks should always be looking to find the best-performing companies in the group. Is Cabot (CBT) one of those stocks right now? Let's take a closer look at the stock's year-to-date performance to find out. The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. ...

As mentioned above, the Scores are designed to work with the Zacks Rank, so any change to a company's earnings outlook should be a deciding factor when picking which stocks to buy. Stock to Watch: Cabot (CBT) It also boasts a Value Style Score of B thanks to attractive valuation metrics like a forward P/E ratio of 14.76; value investors should take notice. For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of diffe ...

Core Viewpoint - Growth investors are focused on stocks with above-average financial growth, but identifying stocks that can fulfill their potential is challenging [1] Group 1: Company Overview - Cabot (CBT) is recommended as a cutting-edge growth stock with a favorable Growth Score and a top Zacks Rank [2] - The historical EPS growth rate for Cabot is 18.4%, with projected EPS growth of 26.1% this year, significantly higher than the industry average of 10.3% [4] Group 2: Key Metrics - Cabot has an asset utilization ratio (sales-to-total-assets ratio) of 1.1, indicating it generates $1.1 in sales for every dollar in assets, outperforming the industry average of 0.73 [5] - The company's sales are expected to grow by 1.9% this year, compared to an industry average of 0% [6] Group 3: Earnings Estimates - The current-year earnings estimates for Cabot have been revised upward, with the Zacks Consensus Estimate increasing by 0.1% over the past month [7] - Cabot has earned a Growth Score of A and carries a Zacks Rank 2 due to positive earnings estimate revisions [8] Group 4: Investment Potential - The combination of strong growth metrics and positive earnings revisions suggests that Cabot is a potential outperformer and a solid choice for growth investors [10]